Lipocalin 2 attenuates oligodendrocyte loss and immune cell infiltration in mouse models for multiple sclerosis. Issue 11 (20th July 2022)

• Record Type: Journal Article
• Authors: Gasterich, Natalie; Bohn, Amelie; Sesterhenn, Anika; Nebelo, Frederik; Fein, Lena; Kaddatz, Hannes; Nyamoya, Stella; Kant, Sebastian; Kipp, Markus; Weiskirchen, Ralf; Zendedel, Adib; Beyer, Cordian; Clarner, Tim
• Is Part Of: Glia. Volume 70:Issue 11(2022)
• Page Start: 2188
• Page End: 2206
• Publication Date: 2022-07-20
• Subjects: Cup/EAE -- cuprizone -- degeneration -- MS lesions -- reactive astrocytes; Neuroglia -- Periodicals; Neurology -- Periodicals; 611.0188
• DOI: 10.1002/glia.24245
• Languages: English
• ISSNs: 0894-1491

Abstract

Abstract: Multiple sclerosis (MS) is a central nervous system disease characterized by both degenerative and inflammatory processes. Various mediators are involved in the interplay of degeneration and innate immunity on one hand and peripheral adaptive immunity on the other hand. The secreted protein lipocalin 2 (LCN2) is an inflammatory modulator in a variety of pathologies. Although elevated intrathecal levels of LCN2 have been reported in MS patients, it's functional role is widely unknown. Here, we identified a subpopulation of astrocytes as a source of LCN2 in MS lesions and respective animal models. We investigated the functional role of LCN2 for both autoimmune and degenerative aspects in three MS mouse models including both wild type (WT) and Lcn2 −/− mouse strains. While the experimental autoimmune encephalomyelitis (EAE) model reflects primary autoimmunity, the cuprizone model reflects selective oligodendrocyte loss and demyelination. In addition, we included a combinatory Cup/EAE model in which primary cytodegeneration is followed by inflammatory lesions within the forebrain. While in the EAE model, the disease outcome was comparable in between the two mouse strains, cuprizone intoxicated Lcn2 −/− animals showed an increased loss of oligodendrocytes. In the Cup/EAE model, Lcn2 −/− animals showed increased inflammation when compared to WT mice. Together, our results highlight LCN2 as a potentially protective molecule in MS lesion formation, which might be able to limit loss of oligodendrocytes immune‐cell invasion. Despite these findings, it is not yet clear which glial cell phenotype (and to which extent) contributes to the observed neuroprotective effects, that is, microglia and/or astroglia or even endothelial cells in the brain. Main Points: Astrocytes express Lipocalin 2 (LCN2) in multiple sclerosis (MS) animal models and the active rim of MS lesions. Oligodendrocyte loss was increased in Cup intoxicated Lcn2 −/− animals. In Cup/experimental autoimmune encephalomyelitis, perivascular cuffs, monocytes/microglia and T‐cells were increased in Lcn2 −/− animals.